Page last updated: 2024-08-25

lf 1695 and calcimycin

lf 1695 has been researched along with calcimycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annat, J; Derrepas, P; Dutartre, P; Pascal, M1
Chap, H; Douste-Blazy, L; Hullin, F; Pascal, M; Ragab-Thomas, JM; Sepulchre, C1

Other Studies

2 other study(ies) available for lf 1695 and calcimycin

ArticleYear
Implications of prostaglandin E2 synthesis and phospholipase C activation in potentiation of T-cell proliferation by LF 1695.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:5

    Topics: Animals; Calcimycin; Calcium; Cells, Cultured; Concanavalin A; Dinoprostone; Inositol Phosphates; Lymphocyte Activation; Mice; Piperidines; Signal Transduction; Spleen; T-Lymphocytes; Tetradecanoylphorbol Acetate; Type C Phospholipases

1991
Stimulation of 12-HETE production in human platelets by an immunomodulator, LF 1695. Evidence for activation of arachidonate liberation coupled to cyclo-oxygenase inhibition.
    Biochemical pharmacology, 1989, Sep-01, Volume: 38, Issue:17

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Adjuvants, Immunologic; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcimycin; Cyclooxygenase Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin

1989